Replies to post #107 on Conatus Pharmaceuticals Inc. (CNAT)

[MASTERTRADER]

Look at the competitor's valuations with $0 revenues. We're talkin about Billions of dollars of valuation. CNAT most likely will pass their phase2 trial with success and all bets will be off to get a share below $20. Day is not far away imo since the trial started on March 3rd.

I got my tickets............. ;-)